FOXO4 Antikörper (Forkhead Box O4) (pThr451) (Cy5)

Details for Product anti-FOXO4 Antibody No. ABIN1704764
Antigen
  • FOXO4
  • foxo4
  • AFX
  • AFX1
  • MLLT7
  • Afxh
  • Mllt7
  • afx
  • RGD1561201
  • forkhead box O4
  • forkhead box O4 L homeolog
  • FOXO4
  • foxo4.L
  • Foxo4
Epitop
pThr451
61
36
35
21
13
10
9
8
8
7
6
5
3
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reaktivität
Human, Maus, Ratte (Rattus)
333
186
114
15
10
7
7
5
5
3
3
1
1
Wirt
Kaninchen
311
17
5
Klonalität
Polyklonal
Konjugat
Dieser FOXO4 Antikörper ist konjugiert mit Cy5
14
11
11
11
11
11
10
6
6
3
3
3
3
3
3
3
3
1
Applikation
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
217
115
96
40
38
36
20
9
5
5
2
Optionen
Immunogen KLH conjugated synthetic phosphopeptide derived from human FOXO4 around the phosphorylation site of Thr451
Isotyp IgG
Reinigung Purified by Protein A.
Plasmids, Primers & others Plasmide, Primers & weitere FOXO4 products on genomics-online (e.g. as negative or positive controls)
Antigen
Andere Bezeichnung Foxo4 (FOXO4 Antibody Abstract)
Hintergrund

FOXO4 is a forkhead transcription factor involved in the regulation of the insulin signaling pathway. It binds to insulin-response elements (IREs) and can activate transcription of IGFBP1. FOXO4 down-regulates expression of HIF1A and suppresses hypoxia-induced transcriptional activation of HIF1A-modulated genes. It is also involved in negative regulation of the cell cycle.

Synonyms: FOXO4 phospho T451,p-FOXO4 phospho T451, AFXSer197, Fork head domain transcription factor AFX1, AFX, AFX1, Afxh, ALL1-fused gene from X chromosome, Fork head domain transcription factor AFX1, Forkhead box O4, Forkhead box protein O4, FOXO 4, Mixed lineage leukemia, translocated to, 7, MLLT7, Myeloid lymphoid or mixed lineage leukemia translocated to 7, Myeloid/lymphoid or mixed lineage leukemia, translocated to, 7, Putative fork head domain transcription factor AFX1, FOXO4_HUMAN.

Gen-ID 4303
Pathways Zellzyklus, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Regulation of Muscle Cell Differentiation
Applikations-hinweise IF(IHC-P) 1:50-200
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Lagerung 4 °C
Informationen zur Lagerung Store at 4°C
Haltbarkeit 12 months